DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20163236

Drug utilization study of atopic dermatitis in a tertiary care hospital

Veena Rani Vemuri, Usha V. Nayak

Abstract


Background: Atopic dermatitis is a chronic relapsing hypersensitivity manifestation of the skin which has shown an increasing prevalence world over. It ranges from a mild atopic itch to an unrelenting chronic eczema. Its prevalence which is on the rise necessitates a rational approach to the diagnosis and treatment.

Methods: A prospective study was conducted for a period of six months and 245 prescriptions were collected after obtaining requisite permission and a proper informed consent. The data was analysed by using WHO drug use indicators.

Results: Of the 245 prescriptions analysed, there was a female predominance with a female to male ratio of 1.63:1. Age group presenting more with the symptoms of atopic dermatitis was 20 to 29 years. Antihistamines were the most commonly prescribed medication (221), Emollients were present in 193 prescriptions. Topical steroids were received by 150 patients of whom 51 were prescribed as an FDC. Tacrolimus was given to 17 patients.

Conclusions: It is essential to rule out helminthic infestation, scabies and seborrhoea dermatitis to make a proper diagnosis of atopic dermatitis. More generic prescribing wherever possible might help to reduce the cost per patient.


Keywords


AD, Atopic eczema, Drug utilization study, Topical corticosteroids, Topical calcineurin inhibitors, Tacrolimus

Full Text:

PDF

References


Dhar S. Atopic dermatitis: Indian scenario. Indian J Dermatol Venereol Leprol. 1999;65:253-7.

Sharma P, Kapoor B. Study of prescribing pattern for rational drug therapy. JK Science. 2003;5(3):107-9.

Tikoo D, Chopra SC, Kaushal S, Dogra A. Evaluation of drug use pattern in dermatology as a tool to promote rational prescribing. JK science. 2011;13(3):128-31.

Lebwohl MG, Del Rosso JQ, Abramovits W, Berman B, Cohen DE, Guttman-Yassky E, et al. Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol. 2013;6(7):S2-S18.

Rashmi S, Amrinder K. J Clinico-Epidemiological Profile And Factors Affecting Severity Of Atopic Dermatitis In North Indian Children. 2004;49(3):117-22.

Dhar S, Kanwar AJ. Epidemiology and clinical pattern of atopic dermatitis in North Indian pediatric population. Pediatr Dermatol. 1998;15:347-51.

Dhar S, Mandal B, Ghosh A. Epidemiology and clinical pattern of atopic dermatitis in 100 children seen in city hospital. Indian J Dermatol. 2002;47:202-4.

Karthikeyan K, Thappa DM, Jeevankumar B. Pattern of pediatric dermatoses in a referral center in South India. Indian Pediatr. 2004;41:373-7.

Ashcroft Darren M, Paul D, Ruth G, Ken S, Williams Hywel C. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ. 2005;330:516.

Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135:1522-5.

Boguniewicz M, Fiedler VC, Raimer S, Lawrence I, Leung D, Hanifin J. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol. 1998;102:637-44.

Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 1997;337:816-21.

Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol. 2002;109:547-55.

Klein PA, Richard AF, Clark. An evidence based review of efficacy of antihistamines in relieving pruritus in Atopic dermatitis. Arch Dermatol. 1999;135:1522-5.

Allen HB, Vaze ND, Choi C, Hailu T, Tulbert BH, Cusack CA, et al. The presence and impact of biofilm-producing staphylococci in atopic dermatitis JAMA dermatol. 2014;150(3):260-5.

Bunikowski R, Mielke M, Skarabis H, Worm M, Anagnostopoulos I, Kolde G, et al. Evidence for a disease promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol. 2000;105:814-9.